News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
228 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (18781)
Month
January (4345)
February (4356)
March (4475)
April (4721)
May (4999)
June (4103)
July (3643)
August (3329)
September (4039)
October (5055)
November (4470)
December (3799)
Day
1 (309)
2 (217)
3 (119)
4 (10)
5 (15)
6 (240)
7 (330)
8 (243)
9 (293)
10 (101)
11 (2)
12 (13)
13 (228)
14 (250)
15 (299)
16 (255)
17 (104)
18 (5)
19 (7)
20 (208)
21 (277)
22 (218)
23 (219)
24 (80)
25 (4)
26 (9)
27 (24)
28 (229)
29 (306)
30 (261)
31 (124)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Business
Epic Sciences Launches New Corporate Branding and Website
Epic Sciences, Inc. announced the launch of a new brand identity, redesigned logo, tagline and website.
May 13, 2019
·
3 min read
Deals
Trovagene Announces Equity Investment of $1.5 Million at Premium to Market Price from Institutional Investor, Lincoln Park Capital
Additional funding further extends runway for Trovagene to accelerate clinical development of onvansertib for the treatment of cancers where new therapeutic options are most needed
May 13, 2019
·
6 min read
Business
Aethlon Medical Announces Collaboration With Prostate On-Site Project (POP), Host Of The Jerry Colangelo Sports Legend Golf Classic, To Engage With Participants For CTE Studies
Company also announces issuance of European patent covering TAUSOME™ technology
May 13, 2019
·
7 min read
Deals
Check-Cap Reports First Quarter 2019 Financial Results
Initiates U.S. pilot study of C-Scan® at NYU School of Medicine and Mayo Clinic
May 13, 2019
·
5 min read
Business
Proteostasis Therapeutics Appoints Dr. Badrul Chowdhury, Former FDA Director of Pulmonology, Allergy, and Rheumatology, to Board of Directors
Proteostasis Therapeutics, Inc. announced that Badrul A. Chowdhury, M.D., Ph.D., has been appointed to the Company’s Board of Directors.
May 13, 2019
·
5 min read
Deals
Aquestive Therapeutics to Present at Two Upcoming Investor Conferences
Aquestive Therapeutics, Inc. announced that management will present at the 2019 RBC Capital Markets Global Healthcare Conference to be held in New York, NY on May 21-22, and the 20th Annual B.
May 13, 2019
·
1 min read
Business
Cantel Promotes Peter Clifford to Chief Operating Officer and Appoints Shaun Blakeman as Chief Financial Officer
Leadership changes to advance growth and strengthen focus to better align with business needs
May 13, 2019
·
3 min read
Business
2019 Penile Traction Device: Who is the Inventor?
Andromedical certifies that Dr. Eduardo Gomez de Diego is the inventor and the owner of the patents of the penile traction device, which is a medical device to change the morphology of the penis.
May 13, 2019
·
2 min read
Business
Alzheimer’s Clinical Trials Consortium Selects Elenbecestat and BAN2401 for Upcoming Clinical Studies on Prevention of Alzheimer’s Disease - May 13, 2019
The Alzheimer’s Clinical Trials Consortium and Eisai Co., Ltd. announced that the investigational oral BACE inhibitor elenbecestat and the investigational anti-amyloid beta protofibril antibody BAN2401, which are currently being evaluated as treatments for early Alzheimer’s disease, have been selected by the ACTC as treatments to be evaluated in upcoming clinical studies targeting primary prevention and secondary prevention of AD.
May 13, 2019
·
6 min read
Business
Pulse Systems Announces New East Coast Development Center In Marlborough, MA
California-based medical industry supplier adds prototyping facility to service the Eastern U.S. market
May 13, 2019
·
3 min read
Previous
7 of 23
Next